Abstract
Objectives To describe the effect of combined oral contraceptives (COCs) on matrix metalloproteinases MMP-2 and MMP-9 activity and compare MMP activity in women taking a COC with or without doxycycline. Study design Subjects (n= 20) underwent endometrial biopsies (1) in the late luteal phase of a baseline cycle prior to initiating COCs, (2) on days 19-21 while taking COCs in a standard 28-day cycle (7-day hormone-free interval) and (3) on days 26-28 while taking active COCs continuously for a 28-day cycle. During the continuous COC cycle, they were randomized to receive daily subantimicrobial dose doxycycline 40 mg or placebo. Results Compared to baseline, COC treatment increased MMP-2 (p<.001) and MMP-9 (p<.001). MMP activity was lower in subjects taking a COC with doxycycline compared to those receiving placebo although only significantly lower for MMP-2 latent form (p=.002). Conclusions Unscheduled bleeding with COCs may be the result of increased endometrial MMPs. Sample size limitations prevent us from determining how doxycycline affects MMP activity in COC users.
Original language | English (US) |
---|---|
Pages (from-to) | 65-69 |
Number of pages | 5 |
Journal | Contraception |
Volume | 93 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2016 |
Keywords
- Combined oral contraceptives
- Doxycycline
- Endometrial biopsy
- Matrix metalloproteinase-2 (MMP-2)
- Matrix metalloproteinase-9 (MMP-9)
ASJC Scopus subject areas
- Reproductive Medicine
- Obstetrics and Gynecology